-
2
-
-
84857091284
-
FISH and chips: The recipe for improved prognostication and outcomes for children with medulloblastoma
-
Ramaswamy V, Northcott PA, Taylor MD. FISH and chips: The recipe for improved prognostication and outcomes for children with medulloblastoma. Cancer Genet 2011; 204:577-588.
-
(2011)
Cancer Genet
, vol.204
, pp. 577-588
-
-
Ramaswamy, V.1
Northcott, P.A.2
Taylor, M.D.3
-
3
-
-
0035799137
-
Parents' accounts of obtaining a diagnosis of childhood cancer
-
Dixon-Woods M, Findlay M, Young B, et al. Parents' accounts of obtaining a diagnosis of childhood cancer. Lancet 2001; 357:670-674.
-
(2001)
Lancet
, vol.357
, pp. 670-674
-
-
Dixon-Woods, M.1
Findlay, M.2
Young, B.3
-
4
-
-
84865139892
-
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma
-
Gerber NU, von Hoff K, von Bueren AO, et al. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. Eur J Cancer 2012; 38:2028-2036.
-
(2012)
Eur J Cancer
, vol.38
, pp. 2028-2036
-
-
Gerber, N.U.1
von Hoff, K.2
von Bueren, A.O.3
-
5
-
-
84859242333
-
Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome
-
Brasme J-F, Grill J, Doz F, et al. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome. PLoS ONE 2012; 7:e33415.
-
(2012)
PLoS ONE
, vol.7
-
-
Brasme, J.-F.1
Grill, J.2
Doz, F.3
-
6
-
-
84866884531
-
Delays in diagnosis of paediatric cancers: A systematic review and comparison with expert testimony in lawsuits
-
Brasme J-F, Morfouace M, Grill J, et al. Delays in diagnosis of paediatric cancers: A systematic review and comparison with expert testimony in lawsuits. Lancet Oncol 2012; 13:e445-e459.
-
(2012)
Lancet Oncol
, vol.13
-
-
Brasme, J.-F.1
Morfouace, M.2
Grill, J.3
-
7
-
-
0036705663
-
Latency between symptom onset and diagnosis of pediatric brain tumors: An Eastern Canadian geographic study
-
discussion 372-373.
-
Mehta V, Chapman A, McNeely PD, et al. Latency between symptom onset and diagnosis of pediatric brain tumors: An Eastern Canadian geographic study. Neurosurgery 2002; 51:365-372, discussion 372-373.
-
(2002)
Neurosurgery
, vol.51
, pp. 365-372
-
-
Mehta, V.1
Chapman, A.2
McNeely, P.D.3
-
8
-
-
59449108413
-
Does diagnostic delay result in decreased survival in paediatric brain tumours
-
Kukal K, Dobrovoljac M, Boltshauser E, et al. Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr 2008; 168:303-310.
-
(2008)
Eur J Pediatr
, vol.168
, pp. 303-310
-
-
Kukal, K.1
Dobrovoljac, M.2
Boltshauser, E.3
-
9
-
-
84857051497
-
Interval between onset of symptoms and diagnosis of medulloblastoma in children: Distribution and determinants in a population-based study
-
Brasme J-F, Chalumeau M, Doz F, et al. Interval between onset of symptoms and diagnosis of medulloblastoma in children: Distribution and determinants in a population-based study. Eur J Pediatr 2011; 171:25-32.
-
(2011)
Eur J Pediatr
, vol.171
, pp. 25-32
-
-
Brasme, J.-F.1
Chalumeau, M.2
Doz, F.3
-
10
-
-
79960152262
-
The time to diagnosis in childhood lymphomas and other solid tumors
-
Cecen E, Gunes D, Mutafoglu K, et al. The time to diagnosis in childhood lymphomas and other solid tumors. Pediatr Blood Cancer 2011; 57:392-397.
-
(2011)
Pediatr Blood Cancer
, vol.57
, pp. 392-397
-
-
Cecen, E.1
Gunes, D.2
Mutafoglu, K.3
-
11
-
-
84870215426
-
Medulloblastomics: The end of the beginning
-
Northcott PA, Jones DT, Kool M, et al. Medulloblastomics: The end of the beginning. Nat Rev Cancer 2012; 12:818-834.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 818-834
-
-
Northcott, P.A.1
Jones, D.T.2
Kool, M.3
-
12
-
-
79955034739
-
Medulloblastoma comprises four distinct molecular variants
-
Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29:1408-1414.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1408-1414
-
-
Northcott, P.A.1
Korshunov, A.2
Witt, H.3
-
13
-
-
84860821444
-
Molecular subgroups of medulloblastoma: The current consensus
-
Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: The current consensus. Acta Neuropathol 2011; 123:465-472.
-
(2011)
Acta Neuropathol
, vol.123
, pp. 465-472
-
-
Taylor, M.D.1
Northcott, P.A.2
Korshunov, A.3
-
14
-
-
80053980912
-
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
-
Remke M, Hielscher T, Korshunov A, et al. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol 2011; 29:3852-3861.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3852-3861
-
-
Remke, M.1
Hielscher, T.2
Korshunov, A.3
-
15
-
-
84862688169
-
Subgroup-specific alternative splicing in medulloblastoma
-
Dubuc AM, Morrissy AS, Kloosterhof NK, et al. Subgroup-specific alternative splicing in medulloblastoma. Acta Neuropathol 2012; 123:485-499.
-
(2012)
Acta Neuropathol
, vol.123
, pp. 485-499
-
-
Dubuc, A.M.1
Morrissy, A.S.2
Kloosterhof, N.K.3
-
16
-
-
63449115501
-
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
-
Northcott PA, Nakahara Y, Wu X, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009; 41:465-472.
-
(2009)
Nat Genet
, vol.41
, pp. 465-472
-
-
Northcott, P.A.1
Nakahara, Y.2
Wu, X.3
-
17
-
-
79960842253
-
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
-
Northcott PA, Hielscher T, Dubuc A, et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol 2011; 122:231-240.
-
(2011)
Acta Neuropathol
, vol.122
, pp. 231-240
-
-
Northcott, P.A.1
Hielscher, T.2
Dubuc, A.3
-
18
-
-
84864425646
-
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
-
Northcott PA, Shih DJ, Peacock J, et al. Subgroup-specific structural variation across 1, 000 medulloblastoma genomes. Nature 2012; 488:49-56.
-
(2012)
Nature
, vol.488
, pp. 49-56
-
-
Northcott, P.A.1
Shih, D.J.2
Peacock, J.3
-
19
-
-
84878857067
-
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
-
Dubuc AM, Remke M, Korshunov A, et al. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol 2012; 125:373-384.
-
(2012)
Acta Neuropathol
, vol.125
, pp. 373-384
-
-
Dubuc, A.M.1
Remke, M.2
Korshunov, A.3
-
20
-
-
65249186793
-
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors
-
Northcott PA, Fernandez-L A, Hagan JP, et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 2009; 69:3249-3255.
-
(2009)
Cancer Res
, vol.69
, pp. 3249-3255
-
-
Northcott, P.A.1
Fernandez-L, A.2
Hagan, J.P.3
-
21
-
-
84862776537
-
Clonal selection drives genetic divergence of metastatic medulloblastoma
-
Wu X, Northcott PA, Dubuc A, et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 2012; 482:529-533.
-
(2012)
Nature
, vol.482
, pp. 529-533
-
-
Wu, X.1
Northcott, P.A.2
Dubuc, A.3
-
22
-
-
84863393028
-
Molecular subgroups of medulloblastoma: An international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
-
Kool M, Korshunov A, Remke M, et al. Molecular subgroups of medulloblastoma: An international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 2012; 123:473-484.
-
(2012)
Acta Neuropathol
, vol.123
, pp. 473-484
-
-
Kool, M.1
Korshunov, A.2
Remke, M.3
-
23
-
-
79954991010
-
Integrative Genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
-
Cho Y-J, Tsherniak A, Tamayo P, et al. Integrative Genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 2011; 29:1424-1430.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1424-1430
-
-
Cho, Y.-J.1
Tsherniak, A.2
Tamayo, P.3
-
24
-
-
79960119129
-
Adult medulloblastoma comprises three major molecular variants
-
Remke M, Hielscher T, Northcott PA, et al. Adult medulloblastoma comprises three major molecular variants. J Clin Oncol 2011; 29:2717-2723.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2717-2723
-
-
Remke, M.1
Hielscher, T.2
Northcott, P.A.3
-
25
-
-
84862270168
-
The clinical implications of medulloblastoma subgroups
-
Northcott PA, Korshunov A, Pfister SM, et al. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol 2012; 8:340-351.
-
(2012)
Nat Rev Neurol
, vol.8
, pp. 340-351
-
-
Northcott, P.A.1
Korshunov, A.2
Pfister, S.M.3
-
26
-
-
84886725191
-
Recurrence patterns across medulloblastoma subgroups: An integrated clinical and molecular analysis
-
Ramaswamy V, Remke M, Bouffet E, et al. Recurrence patterns across medulloblastoma subgroups: An integrated clinical and molecular analysis. Lancet Oncol 2013; 14:1200-1207.
-
(2013)
Lancet Oncol
, vol.14
, pp. 1200-1207
-
-
Ramaswamy, V.1
Remke, M.2
Bouffet, E.3
-
27
-
-
84892621211
-
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
-
Remke M, Ramaswamy V, Peacock J, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 2013; 126:917-929.
-
(2013)
Acta Neuropathol
, vol.126
, pp. 917-929
-
-
Remke, M.1
Ramaswamy, V.2
Peacock, J.3
-
28
-
-
84862680481
-
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
-
Northcott PA, Shih DJ, Remke M, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 2012; 123:615-626.
-
(2012)
Acta Neuropathol
, vol.123
, pp. 615-626
-
-
Northcott, P.A.1
Shih, D.J.2
Remke, M.3
-
29
-
-
77950497158
-
Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations
-
Tabori U, Baskin B, Shago M, et al. Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol 2010; 28:1345-1350.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1345-1350
-
-
Tabori, U.1
Baskin, B.2
Shago, M.3
-
30
-
-
84885423998
-
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
-
Zhukova N, Ramaswamy V, Remke M, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 2013; 31:2927-2935.
-
(2013)
J Clin Oncol
, vol.31
, pp. 2927-2935
-
-
Zhukova, N.1
Ramaswamy, V.2
Remke, M.3
-
31
-
-
0035871372
-
Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma
-
Halperin EC, Watson DM, George SL. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer 2001; 91:1444-1450.
-
(2001)
Cancer
, vol.91
, pp. 1444-1450
-
-
Halperin, E.C.1
Watson, D.M.2
George, S.L.3
-
32
-
-
79951934386
-
TP53 mutation is frequently associated with CTNNB1 Mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma
-
Pfaff E, Remke M, Sturm D, et al. TP53 mutation is frequently associated with CTNNB1 Mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 2010; 28:5188-5196.
-
(2010)
J Clin Oncol
, vol.28
, pp. 5188-5196
-
-
Pfaff, E.1
Remke, M.2
Sturm, D.3
-
33
-
-
38349087850
-
Brain tumors in children: Initial symptoms and their influence on the time span between symptom onset and diagnosis
-
Reulecke BC, Erker CG, Fiedler BJ, et al. Brain tumors in children: Initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol 2007; 23:178-183.
-
(2007)
J Child Neurol
, vol.23
, pp. 178-183
-
-
Reulecke, B.C.1
Erker, C.G.2
Fiedler, B.J.3
|